Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Interventional Cardiology Devices (Angioplasty, Catheters, Plaque Modification, Hemodynamic Flow Alteration, Guidewire, Introducer Sheath) Market 2017 - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 18 Dec 17

The "Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022" report has been added to Research and Markets' offering.

The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.

Factors driving the growth of this market include rising geriatric population, improving healthcare infrastructure, and increasing incidence of CVD. On the other hand, the stringent regulatory scenario for these devices and the availability of effective first-line treatments is expected to limit market growth in the coming years.

The plaque modification devices market, by type, is categorized into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is estimated to grow at the fastest rate during the forecast period. The increasing demand for technologically advanced thrombectomy devices is a key factor driving the growth of this market.

The angioplasty stents market is segmented drug-eluting stents, bare-metal stents, and bioresorbable stents. The bioresorbable stents segment is the fastest-growing segment of the global angioplasty stents market. Technological advancement in stents is driving the growth of this segment.

Geographically, the interventional cardiology devices market is dominated by North America, followed by Europe in 2017. Asia Pacific is estimated to grow at the fastest rate, due to infrastructural development in its healthcare systems, the rising burden of CVD, and increasing healthcare expenditure in APAC countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Angioplasty Balloons Market, By Type

7 Angioplasty Stents Market, By Type

8 Catheters Market, By Type

9 Plaque Modification Devices Market, By Type

10 Hemodynamic Flow Alteration Devices Market, By Type

11 Other Interventional Cardiology Devices Market, By Type

12 Interventional Cardiology Devices Market, By Region

13 Competitive Landscape

14 Company Profiles

  • Abbott
  • B. Braun
  • Biosensors
  • Biotronik
  • Boston Scientific
  • C. R. Bard
  • Cordis
  • Ivascular
  • Medtronic
  • Terumo

For more information about this report visit

View source version on

Business Wire

Last updated on: 18/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.